TY - JOUR
T1 - Evidence of dysregulation of dendritic cells in primary HIV infection
AU - Lubong Sabado, Rachel
AU - O'Brien, Meagan
AU - Subedi, Abhignya
AU - Qin, Li
AU - Hu, Nan
AU - Taylor, Elizabeth
AU - Dibben, Oliver
AU - Stacey, Andrea
AU - Fellay, Jacques
AU - Shianna, Kevin V.
AU - Siegal, Frederick
AU - Shodell, Michael
AU - Shah, Kokila
AU - Larsson, Marie
AU - Lifson, Jeffrey
AU - Nadas, Arthur
AU - Marmor, Michael
AU - Hutt, Richard
AU - Margolis, David
AU - Garmon, Donald
AU - Markowitz, Martin
AU - Valentine, Fred
AU - Borrow, Persephone
AU - Bhardwaj, Nina
PY - 2010/11/11
Y1 - 2010/11/11
N2 - Myeloid and plasmacytoid dendritic cells (DCs) are important mediators of both innate and adaptive immunity against pathogens such as HIV. During the course of HIV infection, blood DC numbers fall substantially. In the present study, we sought to determine how early in HIV infection the reduction occurs and whether the remaining DC subsets maintain functional capacity. We find that both myeloid DC and plasmacytoid DC levels decline very early during acute HIV infection. Despite the initial reduction in numbers, those DCs that remain in circulation retain their function and are able to stimulate allogeneic T-cell responses, and up-regulate maturation markers plus produce cytokines/chemokines in response to stimulation with TLR7/8 agonists. Notably, DCs from HIV-infected subjects produced significantly higher levels of cytokines/chemokines in response to stimulation with TLR7/8 agonists than DCs from uninfected controls. Further examination of gene expression profiles indicated in vivo activation, either directly or indirectly, of DCs during HIV infection. Taken together, our data demonstrate that despite the reduction in circulating DC numbers, those that remain in the blood display hyperfunctionality and implicates a possible role for DCs in promoting chronic immune activation.
AB - Myeloid and plasmacytoid dendritic cells (DCs) are important mediators of both innate and adaptive immunity against pathogens such as HIV. During the course of HIV infection, blood DC numbers fall substantially. In the present study, we sought to determine how early in HIV infection the reduction occurs and whether the remaining DC subsets maintain functional capacity. We find that both myeloid DC and plasmacytoid DC levels decline very early during acute HIV infection. Despite the initial reduction in numbers, those DCs that remain in circulation retain their function and are able to stimulate allogeneic T-cell responses, and up-regulate maturation markers plus produce cytokines/chemokines in response to stimulation with TLR7/8 agonists. Notably, DCs from HIV-infected subjects produced significantly higher levels of cytokines/chemokines in response to stimulation with TLR7/8 agonists than DCs from uninfected controls. Further examination of gene expression profiles indicated in vivo activation, either directly or indirectly, of DCs during HIV infection. Taken together, our data demonstrate that despite the reduction in circulating DC numbers, those that remain in the blood display hyperfunctionality and implicates a possible role for DCs in promoting chronic immune activation.
UR - http://www.scopus.com/inward/record.url?scp=78149442321&partnerID=8YFLogxK
U2 - 10.1182/blood-2010-03-273763
DO - 10.1182/blood-2010-03-273763
M3 - Article
C2 - 20693428
AN - SCOPUS:78149442321
SN - 0006-4971
VL - 116
SP - 3839
EP - 3852
JO - Blood
JF - Blood
IS - 19
ER -